Ella L. Kim

499 total citations
19 papers, 368 citations indexed

About

Ella L. Kim is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Ella L. Kim has authored 19 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Ella L. Kim's work include Glioma Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ella L. Kim is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ella L. Kim collaborates with scholars based in Germany, Russia and United States. Ella L. Kim's co-authors include Mirjam Renovanz, Alf Giese, Sven R. Kantelhardt, Michael E. Berens, Manfred Westphal, Christian Hagel, Svenja Zapf, Maxim Sorokin, Anton Buzdin and Alonso Barrantes‐Freer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Ella L. Kim

19 papers receiving 363 citations

Peers

Ella L. Kim
Laurine E. Wedekind Netherlands
Petra Ohneseit Germany
Ally Pen Canada
Mengxian Zhang China
Elias A. El-Habr France
Jiang‐Jie Duan China
Amar Desai United States
Xiaoguang Hao China
Joanna Triscott Canada
Talha Anwar United States
Laurine E. Wedekind Netherlands
Ella L. Kim
Citations per year, relative to Ella L. Kim Ella L. Kim (= 1×) peers Laurine E. Wedekind

Countries citing papers authored by Ella L. Kim

Since Specialization
Citations

This map shows the geographic impact of Ella L. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella L. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella L. Kim more than expected).

Fields of papers citing papers by Ella L. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ella L. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella L. Kim. The network helps show where Ella L. Kim may publish in the future.

Co-authorship network of co-authors of Ella L. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ella L. Kim. A scholar is included among the top collaborators of Ella L. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ella L. Kim. Ella L. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Leukel, Petra, et al.. (2021). ALDH1A3 Segregated Expression and Nucleus-Associated Proteasomal Degradation Are Common Traits of Glioblastoma Stem Cells. Biomedicines. 10(1). 7–7. 9 indexed citations
4.
Kim, Ella L., Maxim Sorokin, Sven Rainer Kantelhardt, et al.. (2020). Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma. Cancers. 12(2). 520–520. 44 indexed citations
5.
Kalasauskas, Darius, Maxim Sorokin, Gabriela Salinas, et al.. (2020). Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes. Cancers. 12(3). 570–570. 11 indexed citations
6.
Poddubskaya, Elena, Maxim Sorokin, Andrew Garazha, et al.. (2020). Clinical use of RNA sequencing and oncobox analytics to predict personalized targeted therapeutic efficacy.. Journal of Clinical Oncology. 38(15_suppl). e13676–e13676. 4 indexed citations
7.
Poddubskaya, Elena, Anton Buzdin, Andrew Garazha, et al.. (2019). Oncobox, gene expression-based second opinion system for predicting response to treatment in advanced solid tumors.. Journal of Clinical Oncology. 37(15_suppl). e13143–e13143. 11 indexed citations
8.
Kim, Ella L., Anton Buzdin, Maxim Sorokin, et al.. (2019). RNA-sequencing and bioinformatic analysis to pre-assess sensitivity to targeted therapeutics in recurrent glioblastoma.. Journal of Clinical Oncology. 37(15_suppl). e13533–e13533. 1 indexed citations
9.
Kantelhardt, Sven R., et al.. (2018). Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables. Frontiers in Oncology. 8. 335–335. 60 indexed citations
10.
11.
Kalasauskas, Darius, Mirjam Renovanz, Anton Buzdin, et al.. (2017). Perspectives and Challenges in Molecular-Based Diagnostics and Personalized Treatment for Recurrent High-Grade Gliomas. Journal of Carcinogenesis & Mutagenesis. 8(2). 2 indexed citations
12.
Kalinina, Juliya, Jun Young Ahn, Narra S. Devi, et al.. (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clinical Cancer Research. 22(24). 6256–6265. 52 indexed citations
13.
Stanković, Nevenka Dudvarski, Marcin Teodorczyk, Ella L. Kim, et al.. (2016). No role of IFITM3 in brain tumor formationin vivo. Oncotarget. 7(52). 86388–86405. 4 indexed citations
14.
Barrantes‐Freer, Alonso, Mirjam Renovanz, Marcus Eich, et al.. (2015). CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells. PLoS ONE. 10(6). e0130519–e0130519. 32 indexed citations
15.
Renovanz, Mirjam & Ella L. Kim. (2014). Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment. Frontiers in Oncology. 4. 142–142. 39 indexed citations
16.
Kim, Ella L., et al.. (2008). Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to γ-radiation. Journal of Neuro-Oncology. 91(3). 241–249. 12 indexed citations
17.
Giese, Alf, Christian Hagel, Ella L. Kim, et al.. (1999). Thromboxane synthase regulates the migratory phenotype of human gliomacells. Neuro-Oncology. 1(1). 3–13. 48 indexed citations
18.
Giese, Alf, Christian Hagel, Ella L. Kim, et al.. (1999). Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-Oncology. 1(1). 3–13. 1 indexed citations
19.
Kim, Ella L., et al.. (1989). Purification of a DNA methyltransferase from Bacillus natto B3364. FEBS Letters. 255(2). 361–364. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurine E. Wedekind Breakdown of academic impact, for papers by Petra Ohneseit Breakdown of academic impact, for papers by Ally Pen Breakdown of academic impact, for papers by Mengxian Zhang Breakdown of academic impact, for papers by Elias A. El-Habr Breakdown of academic impact, for papers by Jiang‐Jie Duan Breakdown of academic impact, for papers by Amar Desai Breakdown of academic impact, for papers by Xiaoguang Hao Breakdown of academic impact, for papers by Joanna Triscott Breakdown of academic impact, for papers by Talha Anwar
Rankless by CCL
2026